- MELI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
MercadoLibre (MELI) CORRESPCorrespondence with SEC
Filed: 11 Jun 09, 12:00am
HUNTON & WILLIAMS LLP | ||
RIVERFRONT PLAZA, EAST TOWER | ||
951 EAST BYRD STREET | ||
RICHMOND, VIRGINIA 23219-4074 | ||
TEL 804• 788• 8200 | ||
FAX 804• 788• 8218 | ||
EDWARD W. ELMORE, JR. | ||
DIRECT DIAL: 804-788-7336 | ||
EMAIL: telmore@hunton.com | ||
FILE NO: 59490.000009 |
Re: | MercadoLibre, Inc. Initial SEC Comment Letter for the Form 10-K for the Fiscal Year Ended December 31, 2008 filed on February 27, 2009 Forms 8-K filed on February 24, 2009 and May 6, 2009 File No. 001-33647 |
1. | You disclose that the company is exposed to several market risks but you do not appear to have provided the quantitative disclosure required byItem 305(a) of Regulation S-K for these risks, other than the sensitivity analysis for interest rate risk. Please advise. |
2. | We note your disclosure that “[e]xcept as described above,” there were no changes in your internal controls over financial reporting. In your response letter, please confirm, if correct, that there were changes in your internal control over financial reporting that occurred during your fourth quarter ended December 31, 2008, that have materially affected, or are reasonably likely to materially affect, your internal control over financial reporting; or advise. In addition, in future filings please avoid qualifying your disclosure in this manner, and instead provide an unqualified statement as to whether or not there were changes in your internal control over financial reporting that occurred during the most recent quarter that have materially affected, or are reasonably likely to materially affect, your internal control over financial reporting. We note in this regard that yourForm 10-Q for the quarter ended March 31, 2009, states in an unqualified manner that there were no changes in internal control over financial reporting during the quarter. |
3. | You state that the annual incentive bonuses and the 2008 Long-Term Retention Bonus Plan amounts for the named executive officers were, in part, based on the attainment of certain individual goals. Please expand your disclosure to provide additional detail regarding the individual performance objectives used to determine bonus awards for each of your named executive officers, to the extent such information is material to an understanding of your compensation policies and decisions. See Item 402(b)(2)(vii) of Regulation S-K. |
4. | Please tell us why you have not filed the 2008 Long Term Retention Plan as an exhibit to your Form 10-K pursuant to Item 601 (b)(10)(iii) of Regulation S-K. |
5. | We note that during fiscal 2008 the Company sold its funds receivable to financial institutions and accounted for these transactions as “true sales” in accordance with SFAS140. Please tell us the amount of gains or losses on such sales, if any, for each period presented, including your most recent interim period ended March 31, 2009. If material, tell us how you considered disclosing such amounts pursuant to paragraph17(h)(2) of SFAS 140. Also, tel1 us how you considered providing the disclosures required by paragraph17(h)(4) of SFAS 140. |
Interest expense | ||||
Quarter | in US$ | |||
Q1 2008 | 922,849.69 | |||
Q2 2008 | 813,212.34 | |||
Q3 2008 | 829,013.95 | |||
Q4 2008 | 4,573,326.14 | |||
Q1 2009 | 2,041,211.66 |
6. | We note your disclosure on page 40 where you state that the financial charge for transactions where you finance extended payment terms internally is recognized over the life of the installment financing. Please describe the nature and length of extended payment terms offered to your customers in further detail. Additionally, tell us how these payment terms impact the Company’s assessment of the timing of revenue recognition (i.e. whether collection reasonably assured) and how you considered disclosing such information pursuant to Question 1 of SAB Topic 13.B. In this regard, we also note that the allowance for doubtful accounts was 69% and 67% of gross receivables for fiscal 2008 and 2007, respectively. |
7. | We note that your Argentine subsidiary is a beneficiary of a 60% relief of total income taxes for ten years. Tell us the aggregate dollar per share effect on earnings for all periods presented and, if material, how you considered disclosing this information pursuant to SAB Topic 11C. Additionally, tell us how you considered specifying the termination date of this tax holiday. |
8. | Please provide us with an analysis of how you determined that the acquired trademarks from your acquisition of Classified Media Group, Inc. have an indefinite useful life. In your response, please tell us why you believe that no legal, regulatory, contractual, competitive, economic, expected use or other factors could limit the useful life of these intangible assets pursuant to paragraph 11 of SFAS 142. |
a. | The expected use of the asset by the entity: TuCarro is one of the most well-known online brands in Venezuela and Colombia and is the leading trademark in the car and real estate online classifieds in these countries, with no close competitor. As a result, we intend to use this trademark indefinitely. |
b. | The expected useful life of another asset or a group of assets to which the useful life of the intangible asset may relate: The useful life of the trademark is not related to another asset. |
c. | Any legal, regulatory, or contractual provisions that may limit the useful life: We are not aware of any legal, regulatory or contractual limitation on the trademark’s useful life other than routine renewals. |
d. | The entity’s own historical experience in renewing or extending similar arrangements (consistent with the intended use of the asset by the entity), regardless of whether those arrangements have explicit renewal or extension provisions. In the absence of that experience, the entity shall consider the assumptions that market participants would use about renewal or extension (consistent with the highest and best use of the asset by market participants), adjusted for entity-specific factors in this paragraph: The Company does not have historical experience in renewing or extending similar arrangements. In addition, in the markets where TuCarro trademark operates, there are no other significant participants. |
e. | The effects of obsolescence, demand, competition, and other economic factors (such as the stability of the industry, known technological advances, legislative action that results in an uncertain or changing regulatory environment, and expected changes in distribution channels): As described above, in the markets where the TuCarro trademark operates, there is no significant competition. We expect to continuously invest in technological advances to address a growing demand and update our business under the TuCarro trademark instead of creating a new trademark. |
f. | The level of maintenance expenditures required to obtain the expected future cash flows from the asset (for example, a material level of required maintenance in relation to the carrying amount of the asset may suggest a very limited useful life): Given current and estimated future business margins and its economies of scale, we will continue to invest in this trademark at an accelerated pace to maintain an updated and positive-cash-flow business structure. |
9. | We note on page F-28 that the Company acquired certain URLs, domain names, trademarks, databases and intellectual property rights that are used or useful in connection with the online platforms of the acquired entities. However, based on your disclosures on page F-30, it appears that you only assigned value to customer lists and non-compete agreements. Tell us how you considered assigning value to the other acquired identifiable intangible assets pursuant to paragraph 39 of SFAS 141. In this regard, we note that trademarks, internet domain names, databases, and patented or unpatented technology are examples of intangible assets that meet the criteria for recognition as an asset apart from goodwill pursuant to paragraph A14 of SFAS 141. |
10. | Your disclosures indicate that you issued shares under your long-term retention plan. Tell us how you considered the disclosure requirements of paragraph A240(f) of SFAS 123(R), as you do not appear to disclose such information in either Note 13 or Note 17. |
Applicable / Not | ||||
Disclosure requirement | Applicable | Reference to the FS | ||
a. A description of the share-based payment arrangement(s), including the general terms of awards under the arrangement(s), such as the requisite service period(s) and any other substantive conditions (including those related to vesting), the maximum contractual term of equity (or liability) share options or similar instruments, and the number of shares authorized for awards of equity share options or other equity instruments. An entity shall disclose the method it uses for measuring compensation cost from share-based payment arrangements with employees | Applicable | See note 17 to our Financial Statements included in our Form 10-K | ||
b. For the most recent year for which an income statement is provided: | ||||
(1) The number and weighted-average exercise prices (or conversion ratios) for each of the following groups of share options (or share units): (a) those outstanding at the beginning of the year, (b) those outstanding at the end of the year, (c) those exercisable or convertible at the end of the year, and those (d) granted, (e) exercised or converted, (f) forfeited, or (g) expired during the year. | Not applicable because the Company is not granting options | Not applicable | ||
(2) The number and weighted-average grant-date fair value (or calculated value for a nonpublic entity that uses that method or intrinsic value for awards measured pursuant to paragraphs 24 and 25 of this Statement) of equity instruments not specified in paragraph A240(b)(1) (for example, shares of nonvested stock), for each of the following groups of equity instruments: (a) those nonvested at the beginning of the year, (b) those nonvested at the end of the year, and those (c) granted, (d) vested, or (e) forfeited during the year. | Not applicable because the Company is not granting options | Not applicable |
c. For each year for which an income statement is provided: | ||||
(1) The weighted-average grant-date fair value (or calculated value for a nonpublic entity that uses that method or intrinsic value for awards measured at that value pursuant to paragraphs 24 and 25 of this Statement) of equity options or other equity instruments granted during the year. | Applicable | See note 17 to our Financial Statements included in our Form 10-K | ||
(2) The total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year. | Not applicable because the Company is not granting options | Not applicable | ||
d. For fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: | ||||
(1) The number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding. | Not applicable because the Company is not granting options | Not applicable | ||
(2) The number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) currently exercisable (or convertible). | Not applicable because the Company is not granting options | Not applicable |
e. For each year for which an income statement is presented: | ||||
(1) A description of the method used during the year to estimate the fair value (or calculated value) of awards under share-based payment arrangements. | Applicable | See note 17 to our Financial Statements included in our Form 10-K | ||
(2) A description of the significant assumptions used during the year to estimate the fair value (or calculated value) of share-based compensation awards, including (if applicable): | Applicable | See note 17 to our Financial Statements included in ourForm 10-K. | ||
(a) Expected term of share options and similar instruments, including a discussion of the method used to incorporate the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instrument. | Not applicable because the Company is not granting options | Not applicable | ||
(b) Expected volatility of the entity’s shares and the method used to estimate it. An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility. A nonpublic entity that uses the calculated value method should disclose the reasons why it is not practicable for it to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. | Not applicable because the Company is not granting options | Not applicable | ||
(c) Expected dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. | Not applicable because the Company is not granting options | Not applicable | ||
(d) Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. | Not applicable because the Company is not granting options | Not applicable | ||
(e) Discount for post-vesting restrictions and the method for estimating it. | Not applicable | Not applicable |
f. An entity that grants equity or liability instruments under multiple share-based payment arrangements with employees shall provide the information specified in paragraphs A240(a)—(e) separately for different types of awards to the extent that the differences in the characteristics of the awards make separate disclosure important to an understanding of the entity’s use of share-based compensation. For example, separate disclosure of weighted-average exercise prices (or conversion ratios) at the end of the year for options (or share units) with a fixed exercise price (or conversion ratio) and those with an indexed exercise price (or conversion ratio) could be important. It also could be important to segregate the number of options (or share units) not yet exercisable into those that will become exercisable (or convertible) based solely on fulfilling a service condition and those for which a performance condition must be met for the options (share units) to become exercisable (convertible). It could be equally important to provide separate disclosures for awards that are classified as equity and those classified as liabilities. | See comments in previous items. | See comments in previous items. |
11. | We note your disclosure of non-GAAP EBITDA. Please tell us how you considered Questions 14 and 15 of our Frequently Asked Questions Regarding the Use of Non-GAAP Financial Measures. In this regard, we note that your EBITDA measure is calculated differently than that described as EBITDA in SEC Release No. 33-8176. We also note that you have reconciled this measure to income from operations rather than net income. |
12. | Please explain why there was no income tax adjustment for compensation costs related to acquisitions recorded in fiscal 2008. |
• | the Company is responsible for the adequacy and accuracy of the disclosure in the filing; | ||
• | staff comments or changes to disclosure in response to staff comments do not foreclose the U.S. Securities and Exchange Commission (the “Commission”) from taking any action with respect to the filing; and | ||
• | the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
cc: | Christine Davis Melissa Feider Jacobo Cohen Imach Hernán Kazah Jan Woo Katherine Wray |